264 related articles for article (PubMed ID: 29091189)
41. Outpatient parenteral antibiotic therapy for bone and joint infections: an italian multicenter study.
Esposito S; Leone S; Noviello S; Ianniello F; Fiore M; Russo M; Foti G; Carpentieri MS; Cellesi C; Zanelli G; Cellini A; Girmenia C; De Lalla F; Maiello A; Maio P; Marranconi F; Sabbatani S; Pantaleoni M; Ghinelli F; Soranzo ML; Vigano P; Re T; Viale P; Scudeller L; Scaglione F; Vullo V
J Chemother; 2007 Aug; 19(4):417-22. PubMed ID: 17855186
[TBL] [Abstract][Full Text] [Related]
42. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
Bhavan KP; Brown LS; Haley RW
PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
[TBL] [Abstract][Full Text] [Related]
43. [Evaluation of the effectiveness, safety and costs of outpatient intravenous antimicrobial treatment (OPAT) vs hospitalized in urinary infection in pediatrics].
Peña A; Zambrano A; Alvarado M; Cerda J; Vergara R
Rev Chilena Infectol; 2013 Aug; 30(4):426-34. PubMed ID: 24248113
[TBL] [Abstract][Full Text] [Related]
44. Acute dental infections managed in an outpatient parenteral antibiotic program setting: prospective analysis and public health implications.
Connors WJ; Rabie HH; Figueiredo RL; Holton DL; Parkins MD
BMC Infect Dis; 2017 Mar; 17(1):202. PubMed ID: 28279155
[TBL] [Abstract][Full Text] [Related]
45. Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT).
Durojaiye OC; Morgan R; Chelaghma N; Kritsotakis EI
J Infect; 2021 Dec; 83(6):644-649. PubMed ID: 34614400
[TBL] [Abstract][Full Text] [Related]
46. Daptomycin for outpatient parenteral antibiotic therapy: a European registry experience.
Seaton RA; Gonzalez-Ramallo VJ; Prisco V; Marcano-Lozada M; Gonzalez-Ruiz A; Gallegos B; Menichetti F; Loeffler J; Bouylout K; Chaves RL
Int J Antimicrob Agents; 2013 May; 41(5):468-72. PubMed ID: 23473943
[TBL] [Abstract][Full Text] [Related]
47. Safety and effectiveness of outpatient parenteral antimicrobial therapy in older people.
Mujal A; Sola J; Hernandez M; Villarino MA; Baylina M; Tajan J; Oristrell J
J Antimicrob Chemother; 2016 May; 71(5):1402-7. PubMed ID: 26832749
[TBL] [Abstract][Full Text] [Related]
48. Outpatient parenteral antimicrobial therapy today.
Paladino JA; Poretz D
Clin Infect Dis; 2010 Sep; 51 Suppl 2():S198-208. PubMed ID: 20731577
[TBL] [Abstract][Full Text] [Related]
49. Monitoring of Outpatient Parenteral Antimicrobial Therapy and Implementation of Clinical Pharmacy Services at a Community Hospital Infusion Unit.
Shah PJ; Bergman SJ; Graham DR; Glenn S
J Pharm Pract; 2015 Oct; 28(5):462-8. PubMed ID: 25107418
[TBL] [Abstract][Full Text] [Related]
50. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
[TBL] [Abstract][Full Text] [Related]
51. Efficiency of a self-administered outpatient parenteral antimicrobial therapy (s-opat) for infective endocarditis within the context of a shortened hospital admission based on hospital at home program.
Pajarón M; Lisa M; Fernández-Miera MF; Dueñas JC; Allende I; Arnaiz AM; Sanroma-Mendizábal P; De Berrazueta JR; Fariñas MC;
Hosp Pract (1995); 2017 Dec; 45(5):246-252. PubMed ID: 29090606
[TBL] [Abstract][Full Text] [Related]
52. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system.
Psaltikidis EM; Silva END; Moretti ML; Trabasso P; Stucchi RSB; Aoki FH; Cardoso LGO; Höfling CC; Bachur LF; Ponchet DDF; Colombrini MRC; Tozzi CS; Ramos RF; Costa SMQ; Resende MR
Expert Rev Pharmacoecon Outcomes Res; 2019 Jun; 19(3):341-352. PubMed ID: 30362845
[TBL] [Abstract][Full Text] [Related]
53. The history and evolution of outpatient parenteral antibiotic therapy (OPAT).
Williams DN; Baker CA; Kind AC; Sannes MR
Int J Antimicrob Agents; 2015 Sep; 46(3):307-12. PubMed ID: 26233483
[TBL] [Abstract][Full Text] [Related]
54. Management of suspected Lyme borreliosis: experience from an outpatient parenteral antibiotic therapy service.
White B; Seaton RA; Evans TJ
QJM; 2013 Feb; 106(2):133-8. PubMed ID: 23070203
[TBL] [Abstract][Full Text] [Related]
55. Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.
Suleyman G; Kenney R; Zervos MJ; Weinmann A
J Clin Pharm Ther; 2017 Feb; 42(1):39-43. PubMed ID: 27747899
[TBL] [Abstract][Full Text] [Related]
56. The Impact of Pediatric Outpatient Parenteral Antibiotic Therapy Implementation at a Tertiary Children's Hospital in the United Kingdom.
Patel S; Burzio V; Green H; Rees S; Tebruegge M; Jones C; Faust SN
Pediatr Infect Dis J; 2018 Dec; 37(12):e292-e297. PubMed ID: 29613971
[TBL] [Abstract][Full Text] [Related]
57. Outpatient Parenteral Antibiotic Treatment for Infective Endocarditis: A Prospective Cohort Study From the GAMES Cohort.
Pericà S JM; Llopis J; González-Ramallo V; Goenaga MÁ; Muñoz P; García-Leoni ME; Fariñas MC; Pajarón M; Ambrosioni J; Luque R; Goikoetxea J; Oteo JA; Carrizo E; Bodro M; Reguera-Iglesias JM; Navas E; Hidalgo-Tenorio C; Miró JM;
Clin Infect Dis; 2019 Oct; 69(10):1690-1700. PubMed ID: 30649282
[TBL] [Abstract][Full Text] [Related]
58. Outpatient parenteral antibiotic treatment for infective endocarditis: A retrospective observational evaluation.
Schwiebert DR; Atanze DS; Iroegbu DU; Wilkins DM; Sandoe DJAT
Clin Med (Lond); 2024 May; 24(3):100213. PubMed ID: 38643831
[TBL] [Abstract][Full Text] [Related]
59. Dedicated paediatric Outpatient Parenteral Antimicrobial Therapy medical support: a pre-post observational study.
Mace AO; McLeod C; Yeoh DK; Vine J; Chen YP; Martin AC; Blyth CC; Bowen AC
Arch Dis Child; 2018 Feb; 103(2):165-169. PubMed ID: 28847879
[TBL] [Abstract][Full Text] [Related]
60. Clinical and cost-effectiveness, safety and acceptability of
Mitchell ED; Czoski Murray C; Meads D; Minton J; Wright J; Twiddy M
BMJ Open; 2017 Apr; 7(4):e013560. PubMed ID: 28428184
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]